Clinical Trials Directory

Trials / Completed

CompletedNCT01194362

A Study to Identify Differences in Gene Expression in Patients With Bicuspid and Tricuspid Valve Disease

A Study to Establish Genomic Bio Signatures of Ascending Aortic Aneurysms in Patients With Bicuspid and Tricuspid Aortic Valve Disease With Aortic Stenosis

Status
Completed
Phase
Study type
Observational
Enrollment
91 (actual)
Sponsor
Baylor Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

For this study, blood and tissue samples will be collected in order to perform genetic testing to help researchers gather information about this disease and how and why it affects some patients more than others.

Detailed description

The cause of bicuspid aortic valve (BAV) and its associated co morbidities is unknown. There is, however, evidence supporting a genetic cause for the BAV, Pedigree analysis of familial clustering initially directed investigators to a genetic cause of BAV. Subsequent studies on BAV patients using linkage analysis have demonstrated high heritability. Early identification of those patients with BAV disease who are at risk for ascending aneurysm formation and its complications may allow early intervention to prevent rupture, dissection and emergent cardiac surgery in at risk patients. Conversely, identification of those patients with BAVs not at risk for aortic aneurysm formation would delineate which patients do not need close follow up of aortic size or prophylactic ascending aortic replacement at time of aortic valve replacement.

Conditions

Timeline

Start date
2010-06-20
Primary completion
2022-09-23
Completion
2022-09-23
First posted
2010-09-03
Last updated
2026-01-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01194362. Inclusion in this directory is not an endorsement.

A Study to Identify Differences in Gene Expression in Patients With Bicuspid and Tricuspid Valve Disease (NCT01194362) · Clinical Trials Directory